Osteomyelitis When Empiric Antimicrobial Therapy Has Not Worked

When a patient with osteomyelitis does not respond adequately to the initial course of empiric antimicrobial therapy targeting Staphylococcus aureus, the clinical picture calls for a structured reassessment before the next management step is taken.

Prior Treatment & Failure Condition

The previous line was empiric antimicrobial therapy active against Staphylococcus aureus, initiated after blood culture was obtained. Escalation to this protocol is triggered when that regimen fails to achieve:

Resolution of fever within 3 to 5 days of starting therapy, and/or
A decline in serum CRP of at least 50% within 4 days of therapy.

Next-Line Approach (partial overview)

The next step involves a careful reassessment of the antimicrobial regimen — including its spectrum of activity and penetration to the site of infection — alongside obtaining additional cultures from the affected site(s). Whether surgical intervention is also needed forms part of this structured reassessment.

Full regimen details, sequencing, and surgical criteria are in the complete protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/jpids/piab027

Clinicians should assess the adequacy of the antimicrobial regimen (spectrum of activity, dosage and penetration to the site of infection, and adherence) before deciding on the need to broaden the spectrum or to restart antimicrobials (Good practice statement).

Clinicians should reassess the need for surgical intervention for therapeutic and/or diagnostic purposes (Good practice statement).

View source ↗